These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32385741)

  • 21. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive Disorder.
    Kavanaugh BC; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Schneider MB; Carpenter LL
    J ECT; 2018 Dec; 34(4):258-265. PubMed ID: 29613944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal Anterior Cingulate N-Acetylaspartate and Executive Functioning in Treatment-Resistant Depression After rTMS Therapy.
    Zheng H; Jia F; Guo G; Quan D; Li G; Wu H; Zhang B; Fan C; He X; Huang H
    Int J Neuropsychopharmacol; 2015 May; 18(11):pyv059. PubMed ID: 26025780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression (TRMD) Veteran patients: study protocol for a randomized controlled trial.
    Mi Z; Biswas K; Fairchild JK; Davis-Karim A; Phibbs CS; Forman SD; Thase M; Georgette G; Beale T; Pittman D; McNerney MW; Rosen A; Huang GD; George M; Noda A; Yesavage JA
    Trials; 2017 Sep; 18(1):409. PubMed ID: 28865495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Large-scale structural network change correlates with clinical response to rTMS in depression.
    Nestor SM; Mir-Moghtadaei A; Vila-Rodriguez F; Giacobbe P; Daskalakis ZJ; Blumberger DM; Downar J
    Neuropsychopharmacology; 2022 Apr; 47(5):1096-1105. PubMed ID: 35110687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: A six-month clinical follow-up study.
    Concerto C; Lanza G; Cantone M; Ferri R; Pennisi G; Bella R; Aguglia E
    Int J Psychiatry Clin Pract; 2015; 19(4):252-8. PubMed ID: 26398527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in dorsolateral prefrontal connectivity after rTMS in treatment-resistant depression: a brain perfusion SPECT study.
    Richieri R; Jouvenoz D; Verger A; Fiat P; Boyer L; Lançon C; Guedj E
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1051-1055. PubMed ID: 28154905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bilateral Repetitive Transcranial Magnetic Stimulation Decreases Suicidal Ideation in Depression.
    Weissman CR; Blumberger DM; Brown PE; Isserles M; Rajji TK; Downar J; Mulsant BH; Fitzgerald PB; Daskalakis ZJ
    J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29701939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated HF-rTMS in treatment-resistant unipolar depression: Insights from subgenual anterior cingulate functional connectivity.
    Baeken C; Marinazzo D; Wu GR; Van Schuerbeek P; De Mey J; Marchetti I; Vanderhasselt MA; Remue J; Luypaert R; De Raedt R
    World J Biol Psychiatry; 2014 May; 15(4):286-97. PubMed ID: 24447053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unilateral and bilateral MRI-targeted repetitive transcranial magnetic stimulation for treatment-resistant depression: a randomized controlled study.
    Blumberger DM; Maller JJ; Thomson L; Mulsant BH; Rajji TK; Maher M; Brown PE; Downar J; Vila-Rodriguez F; Fitzgerald PB; Daskalakis ZJ
    J Psychiatry Neurosci; 2016 Jun; 41(4):E58-66. PubMed ID: 27269205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposite effects of high and low frequency rTMS on regional brain activity in depressed patients.
    Speer AM; Kimbrell TA; Wassermann EM; D Repella J; Willis MW; Herscovitch P; Post RM
    Biol Psychiatry; 2000 Dec; 48(12):1133-41. PubMed ID: 11137053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bifrontal active and sham rTMS in treatment-resistant unipolar major depression.
    Valkonen-Korhonen M; Leinola H; Könönen M; Niskanen E; Purhonen M; Pakarinen M; Ruusunen A; Lehto SM; Mervaala E; Honkalampi K; Koivumaa-Honkanen H; Viinamäki H
    Nord J Psychiatry; 2018 Nov; 72(8):586-592. PubMed ID: 30348049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The alteration of retinal nerve fibre layer thickness with repetitive transcranial magnetic stimulation in patients with treatment resistant major depression.
    Genc A; Dalkıran M; Pirdoğan Aydın E; Türkyılmaz Uyar E; Alkan A; Guven D; Özer ÖA; Karamustafalıoğlu O
    Int J Psychiatry Clin Pract; 2019 Mar; 23(1):57-61. PubMed ID: 30596524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frontostriatal Connectivity Changes in Major Depressive Disorder After Repetitive Transcranial Magnetic Stimulation: A Randomized Sham-Controlled Study.
    Kang JI; Lee H; Jhung K; Kim KR; An SK; Yoon KJ; Kim SI; Namkoong K; Lee E
    J Clin Psychiatry; 2016 Sep; 77(9):e1137-e1143. PubMed ID: 27379563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study.
    Sonmez AI; Kucuker MU; Lewis CP; Kolla BP; Doruk Camsari D; Vande Voort JL; Schak KM; Kung S; Croarkin PE
    Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109763. PubMed ID: 31634515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A randomized double-blind sham-controlled comparison of unilateral and bilateral repetitive transcranial magnetic stimulation for treatment-resistant major depression.
    Blumberger DM; Mulsant BH; Fitzgerald PB; Rajji TK; Ravindran AV; Young LT; Levinson AJ; Daskalakis ZJ
    World J Biol Psychiatry; 2012 Sep; 13(6):423-35. PubMed ID: 21736507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, sham-controlled study of maintenance rTMS for treatment-resistant depression (TRD).
    Benadhira R; Thomas F; Bouaziz N; Braha S; Andrianisaina PS; Isaac C; Moulier V; Januel D
    Psychiatry Res; 2017 Dec; 258():226-233. PubMed ID: 28844559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prefrontal cortical blood flow predicts response of depression to rTMS.
    Weiduschat N; Dubin MJ
    J Affect Disord; 2013 Sep; 150(2):699-702. PubMed ID: 23707032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment location in treatment-resistant depression.
    McDonald WM; Durkalski V; Ball ER; Holtzheimer PE; Pavlicova M; Lisanby SH; Avery D; Anderson BS; Nahas Z; Zarkowski P; Sackeim HA; George MS
    Depress Anxiety; 2011 Nov; 28(11):973-80. PubMed ID: 21898711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated intermittent theta burst stimulation treatment in medication-resistant major depression: A fast road to remission?
    Duprat R; Desmyter S; Rudi de R; van Heeringen K; Van den Abbeele D; Tandt H; Bakic J; Pourtois G; Dedoncker J; Vervaet M; Van Autreve S; Lemmens GM; Baeken C
    J Affect Disord; 2016 Aug; 200():6-14. PubMed ID: 27107779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. rTMS with a two-coil array: Safety and efficacy for treatment resistant major depressive disorder.
    Carpenter LL; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Stannard EL; Schneider MB
    Brain Stimul; 2017; 10(5):926-933. PubMed ID: 28642024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.